BIOHARVEST SCIENCES INC.
For the period ended Dec 31, 2024. Filed Mar 31, 2025.
View on SEC.govAbout this filing
The yearly report of certain Canadian companies, filed under a joint US and Canadian system. It is the main yearly account these companies give US investors, largely as filed in Canada.
FY2024 · Filed Mar 31, 2025
Use the contents to explore the available documents and sections.
BHST$1.59+6.7%Stored close · as of Nov 6, 2026
Contents
EX-99.2 · USD in thousands, except per share data
USD in thousands, except per share data
| Note | 2024 | 2023 | |
|---|---|---|---|
| Revenues | 18 | $ 25,188 | $ 12,672 |
| Cost of revenues | 19 | 11,246 | 7,039 |
| Gross profit | 13,942 | 5,633 | |
| Operating expenses | |||
| Research and development | 20 | 4,797 | 3,369 |
| Sales and marketing | 21 | 11,733 | 7,748 |
| General and administrative | 22 | 4,401 | 4,482 |
| Total operating expenses | (20,931) | (15,599) | |
| Operating loss | (6,989) | (9,966) | |
| Finance income | 24 | - | 26 |
| Finance expenses | 23 | 5,916 | 2,624 |
| Net loss before tax | (12,905) | (12,564) | |
| Taxes on income | 15 | 8 | - |
| Net loss and comprehensive loss | $ (12,913) | $ (12,564) | |
| Basic and Diluted loss per share | (0.80) | (*) (0.93) | |
| Weighted Average Number of Shares Outstanding | 16,193,787 | (*)13,533,160 | |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.